Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Jan 5;14:1329317. doi: 10.3389/fimmu.2023.1329317

Corrigendum: Serum IgG antibodies from pregnant women reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein

Elisa Mazzoni 1, Mariantonietta Di Stefano 2, Josè R Fiore 2, Federica Destro 1, Marco Manfrini 1, John Charles Rotondo 1, Maria V Casali 3, Fortunato Vesce 4, Pantaleo Greco 4, Gennaro Scutiero 4, Fernanda Martini 1,*, Mauro G Tognon 1,*
PMCID: PMC10798157  PMID: 38250058

In the published article, there was an error in Figure 2 as published. Some technical problems may have occurred regarding the Figures 2C, D panels. There was an overlapping of two photographs taken at the same time, causing a partial duplication of the same field. The corrected Figure 2 and its caption appear below.

Figure 2.

Figure 2

Inhibition of Simian virus 40 (SV40) cytopathic effect (CPE) in CV-1 infected cells by human immune sera. Inhibition of SV40 CPE in infected cells by human serum samples from pregnant women and non-pregnant women. Upper panel. (A) Negative control represented by uninfected CV-1 cells. (B) Positive control represented by the CPE induced by SV40 in CV-1 infected cells. (C, D) These sera did not inhibit SV40 CPE. (E–G) SV40-positive sera inhibited SV40 CPE with different degrees. (H) This serum sample completely inhibited SV40 CPE. Sample H had an optical density (OD) of 0.876 for the LT mimotopes. Bottom panel: there was a correlation between the OD values and CPE inhibition activity of tested immune sera. Indeed, serum samples C and D that were under the cutoff value did not inhibited SV40 CPE, while sera E, F, and G with an OD in the range of 0.193–0.643 inhibited partially with a different degree SV40 CPE. The serum in H panel, with the higher OD value, inhibited completely SV40 CPE.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES